Over 40% of U.S. adults meet the medical classification for obesity, according to the Centers for Disease Control and ...

A popular diabetes drug just got a major new approval — and it could be a game-changer for millions of Americans at risk for kidney failure.

A new study published in JAMA Ophthalmology reveals that weight loss drugs like Ozempic and similar medications could cause three potentially blinding eye conditions. The research identified ...

By Dani Blum Some people who take drugs like Ozempic have noticed a surprising but welcome side effect: They drink less. A paper published Wednesday offers the strongest evidence yet that this is ...

Earlier animal trials had shown how the glucagon-like peptide 1 receptor agonist (GLP-1RA) semaglutide (Wegovy, Ozempic ... for weight reduction reach 2.4 mg/week," the researchers noted, adding ...

Some people using GLP-1 drugs like Ozempic for weight loss have a problem: Eggs are suddenly expensive and hard to find. Eggs aren't just big with fitness fans and Gaston from "Beauty and the Beast." ...

Steve Christo - Corbis/Corbis via Getty; Getty It has been theorized that Ozempic could potentially help ... The drug — the brand name for the GLP-1 agonist semaglutide — “significantly ...

Then he started taking Ozempic, the Novo Nordisk diabetes drug that is sold under the name Wegovy for obesity. He later switched to Mounjaro, from Eli Lilly, which is sold as Zepbound for obesity.

"Semaglutide, sold by Novo Nordisk as Ozempic for type 2 diabetes and Wegovy for obesity, is part of a class of drugs known as GLP-1 receptor agonists, mimicking the hormone GLP-1 to reduce ...

Dr. Taz Bhatia, a board-certified integrative medicine physician based in Atlanta, recently shared the items that she says “mimic Ozempic, Wegovy, Mounjaro and all the GLP-1 medications” in a ...

Ozempic is a brand name for semaglutide and is a prescription medication developed by leading Danish pharmaceutical company Novo Nordisk. It functions as a glucagon-like peptide-1 (GLP-1 ...